Exisulind
Drug profile
Also known as: aptosyn, sulindac sulfone
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Exisulind is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including Akr1b1, EDNRA and MAPK1.
- Molecular targets: Akr1b1, EDNRA and MAPK1 (3 listed in DrugCentral).
- Molecular formula: C20H17FO4S; molecular weight 372.42 g/mol.
Mechanism & targets
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Aldose reductase | Akr1b1 | unknown | IC50 6.57 |
| Endothelin-1 receptor | EDNRA | unknown | Ki 5.22 |
| Mitogen-activated protein kinase 1 | MAPK1 | unknown | IC50 4.86 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Exisulind is on its molecule page.
| Molecular formula | C20H17FO4S |
|---|---|
| Molecular weight | 372.42 g/mol |
| CAS number | — |
| InChIKey | MVGSNCBCUWPVDA-MFOYZWKCSA-N |
| PubChem CID | 5472495 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Exisulind work?
Its molecular targets in DrugCentral include Akr1b1, EDNRA and MAPK1.
What is the chemical formula of Exisulind?
Exisulind has the molecular formula C20H17FO4S and a molecular weight of 372.42 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3219 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL488025 — compound record and bioactivity
- PubChem CID 5472495 — chemical identifiers
- DrugBank DB06246 — drug record
- FDA UNII K619IIG2R9 — substance identity
- UniProt P25101 (EDNRA) — target protein
- UniProt P28482 (MAPK1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.